Exact Sciences Corp EXAS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:49 PM EST
127.10quote price arrow down-9.29 (-6.81%)
Volume
1,176,366
52 week range
35.25 - 159.54

...

Loading . . .

KEY STATS

  • Open135.51
  • Day High136.16
  • Day Low124.46
  • Prev Close136.39
  • 52 Week High159.54
  • 52 Week High Date01/25/21
  • 52 Week Low35.25
  • 52 Week Low Date03/18/20
  • Market Cap21.491B
  • Shares Out169.09M
  • 10 Day Average Volume2.21M
  • Dividend-
  • Dividend Yield-
  • Beta1.36
  • 1 Year % Change74.63

RATIOS/PROFITABILITY

  • EPS (TTM)-5.54
  • P/E (TTM)-22.92
  • Fwd P/E (NTM)-43.68
  • EBITDA (MRQ)17.609M
  • ROE (MRQ)-33.20%
  • Revenue (MRQ)1.491B
  • Gross Margin (MRQ)76.24%
  • Net Margin (MRQ)-56.90%
  • Debt To Equity (MRQ)56.66%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with...
Kevin Conroy
Chairman
Jeffrey Elliott
Chief Financial Officer
Address
5505 ENDEAVOR LANE
Madison, WI
53719
United States